Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000260325
Ethics application status
Approved
Date submitted
23/12/2016
Date registered
20/02/2017
Date last updated
20/02/2017
Type of registration
Retrospectively registered

Titles & IDs
Public title
The efficacy of intravenous ibuprofen and pregabalin before laparoscopic cholecystectomy surgery on postoperative pain.
Scientific title
Comparison of pregabalin and pregabalin+ intravenous ibuprofen for preemptive (before the procedure) analgesia for laparoscopic cholecystectomy
Secondary ID [1] 290808 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
laparoscopic cholecystectomy procedures 301459 0
Condition category
Condition code
Anaesthesiology 301181 301181 0 0
Pain management

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
For postoperative pain we will give one group of patients ( 29 patients for each group) pregabalin 150 mg oral form 1 hour before the operation. The other group will take pregabalin like group 1 and intravenous ibuprofen 800 mg, 1/2 hour before the operation.
Intervention code [1] 296731 0
Treatment: Drugs
Comparator / control treatment
Grup 1 (only pregabalin) is the control group
Control group
Active

Outcomes
Primary outcome [1] 300598 0
postoperative analgesia which evaluated by 100 mm Visual Analog Scale (VAS)
Timepoint [1] 300598 0
postoperative 0,1,2,4,8,12,24, hour
Secondary outcome [1] 330388 0
patient satisfaction score which evaluated by 100 mm visual analog scale.
Timepoint [1] 330388 0
postoperative 1.2.4.8.12.24. hour

Eligibility
Key inclusion criteria
ASA ( american society of anesthesiologists) Physical Status 1-2,
planned for elective laparoscopyc cholecystectomy
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Emergency cholecystectomy. Antiepileptic drug use, ASA 3 patient groups, Mild or severe renal insufficiency

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 8527 0
Turkey
State/province [1] 8527 0
Konya

Funding & Sponsors
Funding source category [1] 295232 0
University
Name [1] 295232 0
Baskent University
Country [1] 295232 0
Turkey
Primary sponsor type
University
Name
Baskent University
Address
Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA / Turkey
Country
Turkey
Secondary sponsor category [1] 294060 0
None
Name [1] 294060 0
Address [1] 294060 0
Country [1] 294060 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 296574 0
Baskent University Institutional Review Board and Ethics Committee
Ethics committee address [1] 296574 0
Ethics committee country [1] 296574 0
Turkey
Date submitted for ethics approval [1] 296574 0
01/09/2016
Approval date [1] 296574 0
14/10/2016
Ethics approval number [1] 296574 0
KA 16/109

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 71346 0
Dr Omer Karaca
Address 71346 0
Baskent University Konya Research and Application Center Hocacihan mah saray cad no:1 42080 selcuklu/Konya
Country 71346 0
Turkey
Phone 71346 0
+903322570606
Fax 71346 0
+903322570637
Email 71346 0
dromerkaraca@hotmail.com
Contact person for public queries
Name 71347 0
Omer Karaca
Address 71347 0
Baskent University Konya Research and Application Center Hocacihan mah saray cad no:1 42080 selcuklu/Konya
Country 71347 0
Turkey
Phone 71347 0
+903322570606
Fax 71347 0
Email 71347 0
dromerkaraca@hotmail.com
Contact person for scientific queries
Name 71348 0
Omer Karaca
Address 71348 0
Baskent University Konya Research and Application Center Hocacihan mah saray cad no:1 42080 selcuklu/Konya
Country 71348 0
Turkey
Phone 71348 0
+903322570606
Fax 71348 0
Email 71348 0
dromerkaraca@hotmail.com

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseEffects of Single-Dose Preemptive Pregabalin and Intravenous Ibuprofen on Postoperative Opioid Consumption and Acute Pain after Laparoscopic Cholecystectomy.2019https://dx.doi.org/10.1080/08941939.2017.1386738
N.B. These documents automatically identified may not have been verified by the study sponsor.